➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Baxter
AstraZeneca
Colorcon
McKinsey

Last Updated: February 27, 2021

DrugPatentWatch Database Preview

West-ward Pharms Int Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for WEST-WARD PHARMS INT, and what generic and branded alternatives to WEST-WARD PHARMS INT drugs are available?

WEST-WARD PHARMS INT has two hundred and six approved drugs.

There is one tentative approval on WEST-WARD PHARMS INT drugs.

Summary for West-ward Pharms Int
US Patents:0
Tradenames:139
Ingredients:125
NDAs:206

Drugs and US Patents for West-ward Pharms Int

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int IDARUBICIN HYDROCHLORIDE idarubicin hydrochloride INJECTABLE;INJECTION 065288-001 May 15, 2007 AP RX No No   Start Trial   Start Trial
West-ward Pharms Int INDOMETHACIN SODIUM indomethacin sodium INJECTABLE;INJECTION 078713-001 Jul 16, 2008 AP RX No No   Start Trial   Start Trial
West-ward Pharms Int VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride INJECTABLE;INJECTION 062879-001 Aug 2, 1988 DISCN No No   Start Trial   Start Trial
West-ward Pharms Int PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 089523-001 May 3, 1988 DISCN No No   Start Trial   Start Trial
West-ward Pharms Int DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE) dicyclomine hydrochloride INJECTABLE;INJECTION 040465-001 Jun 30, 2003 AP RX No No   Start Trial   Start Trial
West-ward Pharms Int LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 080406-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
West-ward Pharms Int LEUCOVORIN CALCIUM PRESERVATIVE FREE leucovorin calcium INJECTABLE;INJECTION 040347-001 Apr 25, 2000 AP RX No Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for West-ward Pharms Int

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-001 Sep 30, 1982 3,947,569   Start Trial
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-002 Sep 30, 1982 4,110,438   Start Trial
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-003 Sep 30, 1982 3,947,569   Start Trial
West-ward Pharms Int REGLAN metoclopramide hydrochloride INJECTABLE;INJECTION 017862-001 Approved Prior to Jan 1, 1982 4,536,386   Start Trial
West-ward Pharms Int REGLAN metoclopramide hydrochloride INJECTABLE;INJECTION 017862-004 May 28, 1987 4,536,386   Start Trial
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-003 Sep 30, 1982 4,110,438   Start Trial
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-001 Sep 30, 1982 4,110,438   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Moodys
Boehringer Ingelheim
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.